Pharmacy & Distribution Market Research Reports & Industry Analysis
The U.S. two-class system is divided into prescription and nonprescription, or over-the-counter (OTC), medicines. The advantage is that OTC medicines are conveniently sold in a number of retail outlets so that medicines are available when consumers need them. This emphasis on consumer empowerment directly serves two of the most fundamental demands of any workable health care system -- access and affordability.
In recent years, a few of the world’s pharmacy-only national systems have recognized the growing need for greater access to safe and effective medications. Japan, the Netherlands, Denmark, the United Kingdom, Italy, and Argentina all have been part of this trend toward granting consumers increased access to medicines in more outlets.
The drug distribution system in the U.S. is highly regulated by the U.S. Food and Drug Administration (FDA) to ensure only those medications that have a wide enough safety margin and that can be safely and effectively used without the help of a health care professional are available without a prescription.
The somewhat controversial notion of adding a third class of drugs to the U.S. system has been panned by experts and regulators including the AMA and FDA. They say creating a third transition class of drugs would create another health care-disadvantaged population -- those without easy access to a pharmacist at convenient times.
Pharmacy & Distribution Industry Research & Market Reports
-
Diabetic Socks Market Share, Size, Trends, Industry Analysis Report, By Product (Ankle Length, Calf length, Knee length), By Distribution Channel (Hypermarkets, Pharmacy & Drug stores, E-commerce, Others), By Region; Segment Forecast, 2022 - 2030
... global diabetic socks market size is expected to reach USD 285.2 million by 2030 according to a new study by Polaris Market Research. The report “Diabetic Socks Market Share, Size, Trends, Industry Analysis Report, By ... Read More
-
Ankylosing Spondylitis Market by Drug Class (NSAIDs, TNF Inhibitors and Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy): Global Opportunity Analysis and Industry Forecast, 2021–2030
... $5,140.94 million in 2020, and is projected to reach $8,110.59 million by 2030, registering a CAGR of 4.6%% from 2021 to 2030. Ankylosing spondylitis (AS) is a rare type of arthritis that causes pain and ... Read More
-
Retail Clinics and Urgent Care Clinics Consumer Survey 2017
A survey of consumers who visited a retail clinic or an urgent care center, asked questions about visit and satisfaction. Read More